...激酶抑制剂是特异靶向Bcr-Abl的Gleevec（Norvatis公 司），已先后被FDA批准用于慢性髓样白血病（chronic myelogenous leukemia，CML）和胃肠道间质瘤（gastrointestinal stroma tumors，GIST）的治疗。
基于4个网页-相关网页
急性髓样白血病 acute myeloid leukemia ; AML
慢性髓样白血病 Chronic myeloid leukaemia ; CML ; chronic myelogenous leukemia ; Chronic myeloid leukemia
约占急性髓样白血病 acute myeloid leukamia
儿童急性髓样白血病 acute myeloid leukemia
亚急性髓样白血病 Subacute myeloid leukemia
急性髓细胞样白血病 acute myeloid leukemia
慢性髓细胞样白血病 chronic myeloid leukemia
急性髓样细胞白血病 acute myeloid leukemia
应用推荐